期刊文献+

用^(188)Re标记IGF-1类似物的方法 被引量:6

Investigations of Labeling Insulin-like Growth Factor-1 Aanalogue with ^(188)Re
下载PDF
导出
摘要 目的研究标记率高且稳定的188Re标记胰岛素样生长因子-1类似物(IGF-1A)的方法。方法采用直接标记法,改变Tween-80用量、SnCl2.2H2O浓度、IGF-1A用量、洗脱液体积等标记条件;分别在不同时间点测定标记率;标记物中加入生理盐水或人血清后不同时间点测定放射化学纯度。结果最佳标记方法为:将100μl SnCl2.2H2O(10mg/ml)加入50μl IGF-1A(2 mg/ml);300μl Na3PO4和10μl 0.1%Tween-80混匀后加入50μl 188ReO4-洗脱液;在IGF-1A体系中加入洗脱液体系,室温反应30 min;加入500μl NaH2PO4将pH值调节到7.0左右,标记完成。最高标记率为(94.07±0.32)%,胶体含量为(5.50±1.50)%。室温下放置6 h放射化学纯度为(89.07±0.74)%,加入人血清放置24 h后放射化学纯度为(76.57±9.96)%。结论用直接标记法进行188Re标记,IGF-1A标记率高且稳定性良好。 Objective To establish a stable method for labeling insulin-like growth factor-1 analogue (IGF-1A) with ^188Re. Methods The directly labeling method was adopted. Several labeling conditions were tested, such as the volume of Tween-80, the concentration of SnCl2·2H2O, the amount of IGF-1A, and the volume of raRe perrhenate. The labeling efficiency was determined from 15 min to 8 h after labeling The in vitro stability of ^188Re-IGF-1A was analyzed by using human serum or sodium chloride as challenging agent, and the labeling efficiency was determined from 2 to 24 h after added challenging agent. Results The optimum labeling conditions were 10 μl 0.1% Tween-80, 100 μl SnCl2·2H2O (10 mg/ml), 50μA IGF-1A (2 mg/ml), and 50μl raRe perrhenate, incubated 30 min at room temperature. The labeling efficiency of ^188Re-IGF-1A could reach (94.07±0.32)% and the amount of radiocolloid was (5.50±1.50)%. It was (89.07±0.74)% after incubation for 6 h at room temperature, and was (76.57±9.96)% after incubation for 24 h with human serum. Conclusion This method of labeling IGF- 1A with raRe using SnCl2·2H2O is stable and high labeling efficiency can be obtained.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2007年第5期722-725,共4页 Suzhou University Journal of Medical Science
基金 江苏省135医学重点人才资助项目(RC2002035) 苏州市社会发展项目(SSY0617)
关键词 188Re 胰岛素样生长因子-1 标记 ^188Re IGF-1 label
  • 相关文献

参考文献8

  • 1Khandwala HM, Mccutcheon IE, Flyvbjerg A, et al. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth [J]. Endocrine Reviews, 2000, 21 (3): 215-244.
  • 2Tanno S, Tanno S, Mitsuuchi Y, et al. AKT activation upregulates insulin-like growth factor 1 receptor expression and promotes invasiveness of human pancreatic cancer cells[J]. Cancer Research, 2001, 61(2): 589-593.
  • 3Stoehzing O, Liu W, Reinmuth N, et ol. Regulation of hypoxia-inducible facter-1, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor- Ⅰ receptor autocrine loop in human pancreatic cancer [J]. American Journal of Pathology, 2003, 163 (3): 1001-1011.
  • 4Tian X, Chakrabarti A, Amirkhanov NV, et al. External imaging of CCND1,MYC,and KRAS oncogene mRNAs with tumor-targeted radionuelide-PNA-peptide chimeras[J]. Ann NY Acad Sci, 2005(1), 1059: 106-144.
  • 5Thakur ML, Marcus CS, Saeed S, et al. ^99Tc^m-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans[J]. J Nucl Med, 2000, 41(1): 107-110.
  • 6Tian X, Aruva MR, Qin W, et al. External imaging of CCND1 cancer gene activity in experimental human breast cancer xenografts with ^99Tc^m-peptide-peptide nucleic acidpeptide chimeras [J]. J Nucl Med, 2004, 45 (12): 2070-2082.
  • 7Tian X, Aruva MR, Qin W, et al. Noninvasive molecular imaging of MYC mRNA expression in human breast cancer xenografts with a [^99Tc^m]peptide-peptide nucleic acidpeptide chimera[J]. Bioconjug Chem, 2005, 16(1): 70-79.
  • 8章斌,吴翼伟,范我,江一民.用^(188)Re直接标记octreotide[J].中华核医学杂志,2003,23(1):55-56. 被引量:6

共引文献5

同被引文献46

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部